Literature DB >> 8119287

Involvement of a lysine residue in the N-terminal Ni2+ and Cu2+ binding site of serum albumins. Comparison with Co2+, Cd2+ and Al3+.

P J Sadler1, A Tucker, J H Viles.   

Abstract

We report one-dimensional and two-dimensional 1H-NMR studies of the binding of Ni2+, Cu2+, Co2+, Cd2+ and Al3+ to defatted bovine and human serum albumins. The diamagnetic shifts induced by Ni2+, and paramagnetic effects due to Cu2+, were consistent with strong binding to a square-planar site formed by the three N-terminal amino acid residues (Asp-Thr-His for bovine, and Asp-Ala-His for human albumin). In contrast to previous studies on isolated 1-24 N-terminal peptide, a Lys residue also appeared to be involved in the binding site, and is assigned as Lys4. A second His residue is also close to the Cu2+/Ni2+ binding site in bovine serum albumin and is assigned to His59 (not present in human albumin). Co2+ caused specific perturbation of the resonances for the three N-terminal residues as well as those for Lys4. This is the first evidence for Co2+ binding to the N-terminal metal site of serum albumin. Neither Al3+ nor Cd2+ perturbed resonances for the N-terminal amino acids, but bind elsewhere in the protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8119287     DOI: 10.1111/j.1432-1033.1994.tb18614.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  29 in total

1.  Identification of specific protein carbonylation sites in model oxidations of human serum albumin.

Authors:  Ani Temple; Ten-Yang Yen; Scott Gronert
Journal:  J Am Soc Mass Spectrom       Date:  2006-06-05       Impact factor: 3.109

2.  Structural and thermodynamical properties of CuII amyloid-beta16/28 complexes associated with Alzheimer's disease.

Authors:  Luc Guilloreau; Luminita Damian; Yannick Coppel; Honoré Mazarguil; Mathias Winterhalter; Peter Faller
Journal:  J Biol Inorg Chem       Date:  2006-08-22       Impact factor: 3.358

3.  Evaluation of effects of ischaemia on the albumin cobalt binding (ACB) assay in patients exposed to trauma.

Authors:  M Can; S Demirtas; O Polat; A Yildiz
Journal:  Emerg Med J       Date:  2006-07       Impact factor: 2.740

Review 4.  Clinical use of albumin.

Authors:  Paolo Caraceni; Manuel Tufoni; Maria Elena Bonavita
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

5.  Bioactivity of albumins bound to silver nanoparticles.

Authors:  Jessy Mariam; S Sivakami; D C Kothari; P M Dongre
Journal:  Protein J       Date:  2014-06       Impact factor: 2.371

6.  Cobalt-chromium toxic retinopathy case study.

Authors:  Warren Apel; Denis Stark; Anthony Stark; Stephen O'Hagan; Joseph Ling
Journal:  Doc Ophthalmol       Date:  2012-12-15       Impact factor: 2.379

7.  A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin.

Authors:  Kubilay Ukinc; Selcuk Eminagaoglu; Halil Onder Ersoz; Cihangir Erem; Caner Karahan; Arif Bayram Hacihasanoglu; Mustafa Kocak
Journal:  Endocrine       Date:  2009-09-26       Impact factor: 3.633

8.  Effect of common buffers and heterocyclic ligands on the binding of Cu(II) at the multimetal binding site in human serum albumin.

Authors:  Magdalena Sokołowska; Krystyna Pawlas; Wojciech Bal
Journal:  Bioinorg Chem Appl       Date:  2010-05-05       Impact factor: 7.778

9.  Redox homeostasis of albumin in relation to alpha-lipoic acid and dihydrolipoic acid.

Authors:  Pinar Atukeren; Seval Aydin; Ezel Uslu; M Koray Gumustas; Ufuk Cakatay
Journal:  Oxid Med Cell Longev       Date:  2010 May-Jun       Impact factor: 6.543

10.  Relationship Between Hemodynamically Significant Ductus Arteriosus and Ischemia-Modified Albumin in Premature Infants.

Authors:  Hasan Kahveci; Cüneyt Tayman; Fuat Laloğlu; Nazan Kavas; Murat Ciftel; Osman Yılmaz; Esra Laloğlu; Abdulah Erdil; Hülya Aksoy; Salih Aydemir
Journal:  Indian J Clin Biochem       Date:  2015-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.